Literature DB >> 26349037

Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.

Maria A Nagel1, Teresa White1, Nelly Khmeleva1, April Rempel1, Philip J Boyer2, Jeffrey L Bennett3, Andrea Haller4, Kelly Lear-Kaul5, Balasurbramaniyam Kandasmy2, Malena Amato6, Edward Wood7, Vikram Durairaj6, Franz Fogt8, Madhura A Tamhankar9, Hans E Grossniklaus10, Robert J Poppiti11, Brian Bockelman11, Kathy Keyvani12, Lea Pollak13, Sonia Mendlovic14, Mary Fowkes15, Charles G Eberhart16, Mathias Buttmann17, Klaus V Toyka17, Tobias Meyer-ter-Vehn18, Vigdis Petursdottir19, Don Gilden20.   

Abstract

IMPORTANCE: Giant cell arteritis (GCA) is the most common systemic vasculitis in elderly individuals. Diagnosis is confirmed by temporal artery (TA) biopsy, although biopsy results are often negative. Despite the use of corticosteroids, disease may progress. Identification of causal agents will improve outcomes. Biopsy-positive GCA is associated with TA infection by varicella-zoster virus (VZV).
OBJECTIVE: To analyze VZV infection in TAs of patients with clinically suspected GCA whose TAs were histopathologically negative and in normal TAs removed post mortem from age-matched individuals. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study for VZV antigen was performed from January 2013 to March 2015 using archived, deidentified, formalin-fixed, paraffin-embedded GCA-negative, GCA-positive, and normal TAs (50 sections/TA) collected during the past 30 years. Regions adjacent to those containing VZV were examined by hematoxylin-eosin staining. Immunohistochemistry identified inflammatory cells and cell types around nerve bundles containing VZV. A combination of 17 tertiary referral centers and private practices worldwide contributed archived TAs from individuals older than 50 years. MAIN OUTCOMES AND MEASURES: Presence and distribution of VZV antigen in TAs and histopathological changes in sections adjacent to those containing VZV were confirmed by 2 independent readers.
RESULTS: Varicella-zoster virus antigen was found in 45 of 70 GCA-negative TAs (64%), compared with 11 of 49 normal TAs (22%) (relative risk [RR] = 2.86; 95% CI, 1.75-5.31; P < .001). Extension of our earlier study revealed VZV antigen in 68 of 93 GCA-positive TAs (73%), compared with 11 of 49 normal TAs (22%) (RR = 3.26; 95% CI, 2.03-5.98; P < .001). Compared with normal TAs, VZV antigen was more likely to be present in the adventitia of both GCA-negative TAs (RR = 2.43; 95% CI, 1.82-3.41; P < .001) and GCA-positive TAs (RR = 2.03; 95% CI, 1.52-2.86; P < .001). Varicella-zoster virus antigen was frequently found in perineurial cells expressing claudin-1 around nerve bundles. Of 45 GCA-negative participants whose TAs contained VZV antigen, 1 had histopathological features characteristic of GCA, and 16 (36%) showed adventitial inflammation adjacent to viral antigen; no inflammation was seen in normal TAs. CONCLUSIONS AND RELEVANCE: In patients with clinically suspected GCA, prevalence of VZV in their TAs is similar independent of whether biopsy results are negative or positive pathologically. Antiviral treatment may confer additional benefit to patients with biopsy-negative GCA treated with corticosteroids, although the optimal antiviral regimen remains to be determined.

Entities:  

Mesh:

Year:  2015        PMID: 26349037      PMCID: PMC5110206          DOI: 10.1001/jamaneurol.2015.2101

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  10 in total

1.  Varicella zoster virus in the temporal artery of a patient with giant cell arteritis.

Authors:  Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Robert Bert; Don Gilden
Journal:  J Neurol Sci       Date:  2013-10-02       Impact factor: 3.181

2.  Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement.

Authors:  Richard Salazar; Andrew N Russman; Maria A Nagel; Randall J Cohrs; Ravi Mahalingam; D Scott Schmid; Bette K Kleinschmidt-DeMasters; Eve M VanEgmond; Don Gilden
Journal:  Arch Neurol       Date:  2011-04

Review 3.  The molecular and biophysical characterization of the human blood-nerve barrier: current concepts.

Authors:  Eroboghene E Ubogu
Journal:  J Vasc Res       Date:  2013-07-06       Impact factor: 1.934

4.  Varicella zoster virus DNA does not accumulate in infected human neurons.

Authors:  Nicholas L Baird; Jacqueline L Bowlin; Xiaoli Yu; Stipan Jonjić; Jürgen Haas; Randall J Cohrs; Don Gilden
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

5.  Biopsy-negative, varicella zoster virus (VZV)-positive giant cell arteritis, zoster, VZV encephalitis and ischemic optic neuropathy, all in one.

Authors:  Tiago Teodoro; Maria A Nagel; Ruth Geraldes; Teresa White; Ravi Mahalingam; Paulo Batista; Mary Wellish; Jose Pimentel; Nelly Khmeleva; Anna Heintzman; Luísa Albuquerque; Philip J Boyer; Alexander Choe; Rita Peralta; Don Gilden
Journal:  J Neurol Sci       Date:  2014-05-27       Impact factor: 3.181

6.  Varicella Zoster Virus in Ischemic Optic Neuropathy.

Authors:  Liliya Golas; Jeffrey L Bennett; Teresa M White; Barry Skarf; Robert Lesser; Maria A Nagel; Don Gilden
Journal:  Ophthalmology       Date:  2015-06-06       Impact factor: 12.079

7.  Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.

Authors:  Don Gilden; Teresa White; Nelly Khmeleva; Anna Heintzman; Alexander Choe; Philip J Boyer; Charles Grose; John E Carpenter; April Rempel; Nathan Bos; Balasubramaniyam Kandasamy; Kelly Lear-Kaul; Dawn B Holmes; Jeffrey L Bennett; Randall J Cohrs; Ravi Mahalingam; Naresh Mandava; Charles G Eberhart; Brian Bockelman; Robert J Poppiti; Madhura A Tamhankar; Franz Fogt; Malena Amato; Edward Wood; Vikram Durairaj; Steve Rasmussen; Vigdis Petursdottir; Lea Pollak; Sonia Mendlovic; Denis Chatelain; Kathy Keyvani; Wolfgang Brueck; Maria A Nagel
Journal:  Neurology       Date:  2015-02-18       Impact factor: 9.910

8.  Successful Antiviral Treatment of Giant Cell Arteritis and Takayasu Arteritis.

Authors:  Don Gilden; Teresa M White; Lidia Nagae; William H Gurdin; Philip J Boyer; Maria A Nagel
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

9.  VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash.

Authors:  Marc Mathias; Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Vikram D Durairaj; Jeffrey L Bennett; Naresh Mandava; Don Gilden
Journal:  J Neurol Sci       Date:  2013-01-11       Impact factor: 3.181

10.  Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis.

Authors:  Maria A Nagel; Jeffrey L Bennett; Nelly Khmeleva; Alexander Choe; April Rempel; Philip J Boyer; Don Gilden
Journal:  Neurology       Date:  2013-05-01       Impact factor: 9.910

  10 in total
  38 in total

Review 1.  Giant cell arteritis: ophthalmic manifestations of a systemic disease.

Authors:  Elisabeth De Smit; Eoin O'Sullivan; David A Mackey; Alex W Hewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

2.  Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases.

Authors:  Leonard H Calabrese; Fenglong Xie; Huifeng Yun; Kevin L Winthrop; John W Baddley; Cassandra Calabrese; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

Review 3.  Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Authors:  Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

Review 4.  Orbital Vasculitides-Differential Diagnosis.

Authors:  Gabriela M Espinoza; Jessica L Liu
Journal:  Curr Rheumatol Rep       Date:  2019-09-05       Impact factor: 4.592

5.  Blinded search for varicella zoster virus in giant cell arteritis (GCA)-positive and GCA-negative temporal arteries.

Authors:  Don Gilden; Teresa White; Nelly Khmeleva; Bradley J Katz; Maria A Nagel
Journal:  J Neurol Sci       Date:  2016-03-19       Impact factor: 3.181

Review 6.  Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis.

Authors:  Maria A Nagel; Dallas Jones; Ann Wyborny
Journal:  J Neuroimmunol       Date:  2017-03-18       Impact factor: 3.478

Review 7.  Update on the management of giant cell arteritis.

Authors:  Janet Roberts; Alison Clifford
Journal:  Ther Adv Chronic Dis       Date:  2017-03-28       Impact factor: 5.091

Review 8.  Varicella zoster virus and giant cell arteritis.

Authors:  Don Gilden; Maria A Nagel
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

9.  Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.

Authors:  Bryant R England; Ted R Mikuls; Fenglong Xie; Shuo Yang; Lang Chen; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

10.  Varicella Zoster Virus Alters Expression of Cell Adhesion Proteins in Human Perineurial Cells via Interleukin 6.

Authors:  Anna M Blackmon; Christina N Como; Andrew N Bubak; Teresa Mescher; Dallas Jones; Maria A Nagel
Journal:  J Infect Dis       Date:  2019-09-26       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.